Steroid-sensitive nephrotic syndrome: from childhood to adulthood - PubMed (original) (raw)
doi: 10.1053/ajkd.2003.50116.
Nathalie Bocquet, Pierre Taupin, Claire Presne, Marie-France Gagnadoux, Paul Landais, Philippe Lesavre, Dominique Chauveau, Bertrand Knebelmann, Michel Broyer, Jean-Pierre Grünfeld, Patrick Niaudet
Affiliations
- PMID: 12612977
- DOI: 10.1053/ajkd.2003.50116
Steroid-sensitive nephrotic syndrome: from childhood to adulthood
Fadi Fakhouri et al. Am J Kidney Dis. 2003 Mar.
Abstract
Background: The clinical presentation, treatment, and outcome of steroid-sensitive nephrotic syndrome (SSNS) during childhood have been extensively studied. Conversely, few data regarding the outcome in adulthood of childhood SSNS have been published previously. We undertook to conduct a retrospective study of the outcome in adulthood of a large cohort of patients diagnosed with an SSNS during childhood.
Methods: We identified all children born between 1970 and 1975 who had been admitted to our institution for an SSNS. Data regarding the outcome in adulthood of these patients were obtained through mailed questionnaires or phone calls to patients and/or their parents or through attending physicians.
Results: One hundred seventeen patients were identified. Data regarding the outcome of SSNS in adulthood were available for 102 patients (87.2%). Forty-three patients (42.2%) experienced at least one relapse of nephrotic syndrome in adulthood. By univariate analysis, young age at onset (<6 years) and more severe disease in childhood, indicated by a greater number of relapses (12.9 for adulthood relapsers versus 5.4 for adulthood nonrelapsers; P < 0.0001) and more frequent use of immunosuppressors (74.4% versus 31.6%; P < 0.0001) or cyclosporine (42.9% versus 7.3%; P < 0.0001) were predictive of the occurrence of SSNS relapse in adulthood. Conversely, relapse rate in the first 6 months of disease was not predictive of further relapses in adulthood. By multivariate analysis, only number of relapses during childhood was predictive of adulthood relapses (P < 0.0058). Long-term side effects of steroids were found in 44.2% of adulthood relapsers; the most frequent were osteoporosis and excess weight.
Conclusion: The incidence of childhood SSNS relapses in adulthood was relatively high in our study. Further studies are required to assess long-term complications in adults with relapses and a history of prolonged steroid and immunosuppressor use.
Copyright 2003 by the National Kidney Foundation, Inc.
Similar articles
- Long-term outcomes in idiopathic nephrotic syndrome: from childhood to adulthood.
Skrzypczyk P, Panczyk-Tomaszewska M, Roszkowska-Blaim M, Wawer Z, Bienias B, Zajgzkowska M, Kilis-Pstrusinska K, Jakubowska A, Szczepaniak M, Pawlak-Bratkowska M, Tkaczyk M. Skrzypczyk P, et al. Clin Nephrol. 2014 Mar;81(3):166-73. doi: 10.5414/CN108044. Clin Nephrol. 2014. PMID: 24361057 - Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome.
Kyrieleis HA, Levtchenko EN, Wetzels JF. Kyrieleis HA, et al. Am J Kidney Dis. 2007 May;49(5):592-7. doi: 10.1053/j.ajkd.2007.02.270. Am J Kidney Dis. 2007. PMID: 17472840 - Family structure and the course of steroid-sensitive nephrotic syndrome.
Soliday E, Lande MB. Soliday E, et al. Pediatr Nephrol. 2002 Jan;17(1):41-4. doi: 10.1007/s004670200007. Pediatr Nephrol. 2002. PMID: 11793133 - Genetics of childhood steroid-sensitive nephrotic syndrome.
Karp AM, Gbadegesin RA. Karp AM, et al. Pediatr Nephrol. 2017 Sep;32(9):1481-1488. doi: 10.1007/s00467-016-3456-8. Epub 2016 Jul 29. Pediatr Nephrol. 2017. PMID: 27470160 Free PMC article. Review. - Pediatric idiopathic steroid-sensitive nephrotic syndrome: diagnosis and therapy -short version of the updated German best practice guideline (S2e) - AWMF register no. 166-001, 6/2020.
Ehren R, Benz MR, Brinkkötter PT, Dötsch J, Eberl WR, Gellermann J, Hoyer PF, Jordans I, Kamrath C, Kemper MJ, Latta K, Müller D, Oh J, Tönshoff B, Weber S, Weber LT; German Society for Pediatric Nephrology. Ehren R, et al. Pediatr Nephrol. 2021 Oct;36(10):2971-2985. doi: 10.1007/s00467-021-05135-3. Epub 2021 Jun 6. Pediatr Nephrol. 2021. PMID: 34091756 Free PMC article. Review.
Cited by
- To biopsy or not to biopsy a teenager with typical idiopathic nephrotic syndrome? Start steroids first.
Boyer O, Bernardi S, Preka E. Boyer O, et al. Pediatr Nephrol. 2024 Sep 11. doi: 10.1007/s00467-024-06447-w. Online ahead of print. Pediatr Nephrol. 2024. PMID: 39259322 Review. - Timing of relapse as a key indicator of steroid-sparing requirements in childhood idiopathic nephrotic syndrome.
Mohamad K, Zainal H, Abdul Rahim NA, Tengku Hussain TH. Mohamad K, et al. J Nephrol. 2024 Sep 1. doi: 10.1007/s40620-024-02076-6. Online ahead of print. J Nephrol. 2024. PMID: 39218996 - Early Rituximab as an Add-On Therapy in Children With the Initial Episode of Nephrotic Syndrome.
Liu J, Deng F, Wang X, Liu C, Sun S, Zhang R, Zhang A, Jiang X, Yan W, Dou Y, Zhang Y, Xie L, Qian B, Shen Q, Xu H. Liu J, et al. Kidney Int Rep. 2024 Feb 16;9(5):1220-1227. doi: 10.1016/j.ekir.2024.02.1395. eCollection 2024 May. Kidney Int Rep. 2024. PMID: 38707815 Free PMC article. - Impact of childhood nephrotic syndrome on obesity and growth: a prospective cohort study.
Robinson CH, Aman N, Banh T, Brooke J, Chanchlani R, Dhillon V, Langlois V, Levin L, Licht C, McKay A, Noone D, Parikh A, Pearl R, Radhakrishnan S, Rowley V, Teoh CW, Vasilevska-Ristovska J, Parekh RS. Robinson CH, et al. Pediatr Nephrol. 2024 Sep;39(9):2667-2677. doi: 10.1007/s00467-024-06370-0. Epub 2024 Apr 18. Pediatr Nephrol. 2024. PMID: 38637343 - Podocyte number and glomerulosclerosis indices are associated with the response to therapy for primary focal segmental glomerulosclerosis.
de Zoysa N, Haruhara K, Nikolic-Paterson DJ, Kerr PG, Ling J, Gazzard SE, Puelles VG, Bertram JF, Cullen-McEwen LA. de Zoysa N, et al. Front Med (Lausanne). 2024 Mar 6;11:1343161. doi: 10.3389/fmed.2024.1343161. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38510448 Free PMC article.